Log in

Start Your Membership Now

On August 5, 2019, the Centers for Medicare & Medicaid Services (CMS) issued guidance to state Medicaid fee-for-service (FFS) programs and Medicaid managed care organizations (MCOs) on using claims review edits to track opioid use and set prescription limits. The guidance is intended to help states implement new Medicaid Drug Utilization Review (DUR) provisions included in the "Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act” (SUPPORT Act). Under these provisions, the states must establish new drug review and utilization standards to reduce opioid-related fraud, abuse, and misuse. By October 1 . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Federal Government